Big Pharma's TPP Protections For Biologics Face New Attacks
A group of lawmakers, generic-drug industry advocates and public health experts on Friday denounced proposals in the Trans-Pacific Partnership to strengthen exclusivity protections for brand-name biologics, warning that the provisions would...To view the full article, register now.
Already a subscriber? Click here to view full article